Biotech Investors & VC Firms in New York
27 firms in this list, with a median first check of $250K. 4 of them lead rounds. Generated from verified public data and updated continuously.
Lerer Hippeau
New YorkSeed–Series B
Deerfield Management Company
New YorkGrowth–Late Stage
OrbiMed
New YorkPre-Seed–Late Stage
Colle Capital Partners
New YorkPre-Seed–Series A
Artesian
AustraliaPre-Seed–Growth
Casdin Capital
New YorkSeries A–Series C
Apple Tree Venture Management Llc
New YorkPre-Seed–Late Stage
Aisling Capital
New YorkSeed–Series C
Everywhere Ventures
New YorkPre-Seed–Seed
2048 Ventures
New YorkPre-Seed–Seed$500K – $3M
TMV Logistics
New YorkSeed–Series A
Essex Woodlands Healthcare Partners
New YorkGrowth–Late Stage
Adjuvant Capital
New YorkSeries A–Late Stage
Compound
New York
Pathway to Cures
New YorkSeed–Series A
Plum Alley Investments
New YorkPre-Seed–Series A
Logos
San Francisco
Valhalla Ventures
New YorkPre-Seed–Seed$10M
Avant Bio
New YorkSeed–Growth
Ridgeback Capital
MiamiSeed–Late Stage
Averin Capital
New YorkSeed–Growth
Serendipity Impact VC
New YorkSeed–Series B
Allerfund Ventures, Llc
New YorkPre-Seed–Seed
Deviation Capital
New York
Related lists
AI & Machine Learning Investors & VC Firms (857)Investors & VC Firms in New York (784)Investors & VC Firms in San Francisco (649)Fintech Investors & VC Firms (495)Healthtech Investors & VC Firms (481)Investors & VC Firms in Boston (447)Deep Tech Investors & VC Firms (442)SaaS Investors & VC Firms (394)Enterprise Software Investors & VC Firms (360)Biotech Investors & VC Firms (320)
Data sourced from public filings and firms' own websites — see our methodology.